BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2416269)

  • 1. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Kish SJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy: postmortem chemical analysis.
    Young AB
    Ann Neurol; 1985 Nov; 18(5):521-2. PubMed ID: 2866753
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder.
    Kish SJ; Gilbert JJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Apr; 17(4):405-7. PubMed ID: 2408557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 7. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
    Agid Y; Javoy-Agid F; Ruberg M; Pillon B; Dubois B; Duyckaerts C; Hauw JJ; Baron JC; Scatton B
    Adv Neurol; 1987; 45():191-206. PubMed ID: 2881445
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain neurotransmitters in dystonia musculorum deformans.
    Hornykiewicz O; Kish SJ; Becker LE; Farley I; Shannak K
    N Engl J Med; 1986 Aug; 315(6):347-53. PubMed ID: 2426591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ; Shannak K; Hornykiewicz O
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
    Lloyd KG; Hornykiewicz O; Davidson L; Shannak K; Farley I; Goldstein M; Shibuya M; Kelley WN; Fox IH
    N Engl J Med; 1981 Nov; 305(19):1106-11. PubMed ID: 6117011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.
    Le W; Conneely OM; Zou L; He Y; Saucedo-Cardenas O; Jankovic J; Mosier DR; Appel SH
    Exp Neurol; 1999 Oct; 159(2):451-8. PubMed ID: 10506516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regional distribution of gamma-aminobutyric acid, glutamic acid, aspartic acid, dopamine, noradrenaline and serotonin in rat brain].
    Popov N; Pohle W; Rösler V; Matthies H
    Acta Biol Med Ger; 1967; 18(6):695-702. PubMed ID: 5588993
    [No Abstract]   [Full Text] [Related]  

  • 20. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.